|
Stem cell breakthrough offers diabetes hope
April 03, 2008Scientists have discovered a new technique for turning embryonic stem cells into insulin-producing pancreatic tissue in what could prove a significant breakthrough in the quest to find new treatments for diabetes.
The University of Manchester team, working with colleagues at the University of Sheffield, were able to genetically manipulate the stem cells so that they produced an important protein known as a 'transcription factor'.
Stem cells have the ability to become any type of cell, so scientists believe they may hold the key to treating a number of diseases including Alzheimer's, Parkinson's and diabetes.
However, a major stumbling block to developing new treatments has been the difficulty scientists have faced ensuring the stem cells turn into the type of cell required for any particular condition - in the case of diabetes, pancreatic cells.
"Unprompted, the majority of stem cells turn into simple nerve cells called neurons," explained Dr Karen Cosgrove, who led the team in Manchester's Faculty of Life Sciences.
"Less than one per cent of embryonic stem cells would normally become insulin-producing pancreatic cells, so the challenge has been to find a way of producing much greater quantities of these cells."
The pancreas contains different types of specialised cells - exocrine cells, which produce enzymes to aid digestion, and endocrine cells, including beta cells, which produce the hormone insulin to regulate the blood glucose levels. Diabetes results when there is not enough insulin to meet the body's demands.
There are two forms of the disease: type-1 diabetes is due to not enough insulin being produced by the pancreas, while type-2 or adult-onset diabetes occurs when the body fails to respond properly to the insulin that is produced.
The team found that the transcription factor PAX4 encouraged high numbers of embryonic stem cells - about 20% - to become pancreatic beta cells with the potential to produce insulin when transplanted into the body.
Furthermore, the scientists for the first time were able to separate the new beta cells from other types of cell produced using a technique called 'fluorescent-activated cell sorting' which uses a special dye to colour the pancreatic cells green.
"Research in the United States has shown that transplanting a mixture of differentiated cells and stem cells can cause cancer, so the ability to isolate the pancreatic cells in the lab is a major boost in our bid to develop a successful therapy," said Dr Cosgrove.
"Scientists have had some success increasing the number of pancreatic cells produced by altering the environment in which the stem cells develop, so the next stage of our research will be to combine both methods to see what proportions we can achieve."
Scientists believe that transplanting functional beta cells into patients, most likely into their liver where there is a strong blood supply, offers the best hope for finding a cure for type-1 diabetes. It could also offer hope to those with type-2 diabetes whose condition requires insulin injections.
But the more immediate benefit of the team's research is likely to be in providing researchers with a ready-made supply of human pancreatic cells on which to study the disease process of diabetes and test new drugs.
University of Manchester
However, a major stumbling block to developing new treatments has been the difficulty scientists have faced ensuring the stem cells turn into the type of cell required for any particular condition - in the case of diabetes, pancreatic cells.
"Unprompted, the majority of stem cells turn into simple nerve cells called neurons," explained Dr Karen Cosgrove, who led the team in Manchester's Faculty of Life Sciences.
"Less than one per cent of embryonic stem cells would normally become insulin-producing pancreatic cells, so the challenge has been to find a way of producing much greater quantities of these cells."
The pancreas contains different types of specialised cells - exocrine cells, which produce enzymes to aid digestion, and endocrine cells, including beta cells, which produce the hormone insulin to regulate the blood glucose levels. Diabetes results when there is not enough insulin to meet the body's demands.
There are two forms of the disease: type-1 diabetes is due to not enough insulin being produced by the pancreas, while type-2 or adult-onset diabetes occurs when the body fails to respond properly to the insulin that is produced.
The team found that the transcription factor PAX4 encouraged high numbers of embryonic stem cells - about 20% - to become pancreatic beta cells with the potential to produce insulin when transplanted into the body.
Furthermore, the scientists for the first time were able to separate the new beta cells from other types of cell produced using a technique called 'fluorescent-activated cell sorting' which uses a special dye to colour the pancreatic cells green.
"Research in the United States has shown that transplanting a mixture of differentiated cells and stem cells can cause cancer, so the ability to isolate the pancreatic cells in the lab is a major boost in our bid to develop a successful therapy," said Dr Cosgrove.
"Scientists have had some success increasing the number of pancreatic cells produced by altering the environment in which the stem cells develop, so the next stage of our research will be to combine both methods to see what proportions we can achieve."
Scientists believe that transplanting functional beta cells into patients, most likely into their liver where there is a strong blood supply, offers the best hope for finding a cure for type-1 diabetes. It could also offer hope to those with type-2 diabetes whose condition requires insulin injections.
But the more immediate benefit of the team's research is likely to be in providing researchers with a ready-made supply of human pancreatic cells on which to study the disease process of diabetes and test new drugs.
University of Manchester
Stem Cells News and Current Stem Cells Events RSSHow embryonic stem cells develop into tissue-specific cells demonstrated
While it has long been known that embryonic stem cells have the ability to develop into any kind of tissue-specific cells, the exact mechanism as to how this occurs has heretofore not been demonstrated.
Arsenic-based therapy shown to help eradicate leukemia-initiating cells
In both leukemia and solid tumors, there exists among the multitude of warrior cancer cells a small subgroup that work undercover, patiently lying in wait to launch their attacks.
Commencement 2008: Undergrad Has Sweet Success With Invention of Artificial Golgi
An undergraduate student at Rensselaer Polytechnic Institute has learned very quickly that a spoonful of sugar really does help the medicine go down. In fact, with his invention, the sugar may actually be the medicine.
Scientists identify genomic 'fingerprint' for alcohol-induced heart failure
A person with dilated cardiomyopathy has an enlarged and stretched heart cavity, usually too weak to pump normally; most people will go on to develop heart failure.
Controlling embryonic fate by association
Association determines fate in embryonic stem cells, said Baylor College of Medicine researchers in a report that appears in the current issue of the journal Nature Cell Biology.
UCLA stem cell researchers create heart and blood cells from reprogrammed skin cells
Stem cell researchers at UCLA were able to grow functioning cardiac cells using mouse skin cells that had been reprogrammed into cells with the same unlimited properties as embryonic stem cells.
Scientists Find Stem Cells For the First Time in the Pituitary
A team of researchers led by scientists at Cold Spring Harbor Laboratory have for the first time identified stem cells that allow the pituitary glands of mice to grow even after birth.
Heart derived stem cells develop into heart muscle
Dutch researchers at University Medical Center Utrecht and the Hubrecht Institute have succeeded in growing large numbers of stem cells from adult human hearts into new heart muscle cells.
Menstrual blood -- a valuable source of multipotential stem cells?
Researchers seeking new and more abundant sources of stem cells for use in regenerative medicine have identified a potentially unlimited, noncontroversial, easily collectable, and inexpensive source - menstrual blood.
A stem cell type supposed to be crucial for angiogenesis and cancer growth does not exist?
Angiogenesis, the growth of new blood vessels, is a central process in diverse physiological and pathological situations such as healing of wounds and traumas, cardiovascular disorders, inflammatory conditions such as rheumatoid arthritis, and in cancer growth.
More Stem Cells News Articles
 | Embryo: A Defense of Human Life by Robert P. George, Christopher Tollefsen |
 | My Sister's Keeper: A Novel by Jodi Picoult |
 | The Oxygen Revolution: Hyperbaric Oxygen Therapy: The Groundbreaking New Treatment for Stroke, Alzheimer's, Parkinson's, Arthritis, Autism, Learning Disabilities and More by Paul G. Harch, Virginia Mccullough |
 | Miracle Stem Cell Heart Repair: (For Heart Attack, Heart Failure and Bypass Patients) by Christian Wilde |
 | The Stem Cell Dilemma: Beacons of Hope or Harbingers of Doom? by Leo Furcht, William Hoffman |
 | Irreparable Harm by Randy D. Singer |
 | The Stem Cell Divide: The Facts, the Fiction, and the Fear Driving the Greatest Scientific, Political, and Religious Debate of Our Time by Michael Bellomo |
 | The Stem Cell Controversy: Debating the Issues (Contemporary Issue Series) |
 | Stem Cell Century: Law and Policy for a Breakthrough Technology by Russell Korobkin |
 | Umbilical Cord Stem Cell Therapy: The Gift of Healing from Healthy Newborns by David A. Steenblock, Anthony G., Ph.D. Payne |
| © 2008 BrightSurf.com |